Cosmetic cross-reference

Succinic Acid

CAS 110-15-6

Succinic Acid (CAS 110-15-6) is a Phase 3 pharmaceutical compound with 2 bioactivity targets and 2 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
8
SOURCE DrugCentral
Adverse signals
2
SOURCE IUPHAR/BPS
PubMed IDs
2
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Succinic Acid
CAS Number
110-15-6
UNII
AB6MNQ6J6L
InChIKey
KDYFGRWQOYBRFD-UHFFFAOYSA-N
ChEMBL ID
CHEMBL576
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
succinate
natural product
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3
Late-stage clinical development phase from the compound identifier source.
ChEMBL CHEMBL576 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE EMBL-EBI ChEMBL 8 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- AC50 29112.028125 nM 32 -
- EC50 18378.677499999998 nM 8 -
- IC50 32293.125 nM 7 -
- MIC 325 ug.mL-1 4 -
- Potency 11279.866666666669 nM 3 -
- Kd 100000 nM 2 -
Egl nine homolog 1
Enzyme
 IC50 5.52 - Homo sapiens
Succinate receptor 1
GPCR
 EC50 4.7 - Homo sapiens
SOURCE DrugCentral 2 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Therapeutic response decreased 16 29.922 10043414
Emotional distress 12 27.428 10049119

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE IUPHAR/BPS 1 interaction

IUPHAR Ligand-Target Data

Curated ligand-target interaction rows with action, affinity, and literature identifiers.

TargetAction AffinityPubMed
succinate receptor
SUCNR1
 Full agonist 3.0999999046325684 pEC50 15141213|23396314
SOURCE NLM RxNorm 5 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
SUCCINIC ACID 37255 SU MTHSPL
succinic acid 37255 SU MTHSPL
Succinic Acid 37255 SU MTHSPL
succinic acid 37255 IN RXNORM
succinate 1307106 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Succinic Acid used for in pharmaceutical contexts?

Succinic Acid (CAS 110-15-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Succinic Acid?

Succinic Acid has 2 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Therapeutic response decreased, Emotional distress. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Succinic Acid also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Succinic Acid with EU status "permitted".

What clinical phase is Succinic Acid in?

Succinic Acid is rendered with ChEMBL max phase 3.

What bioactivity targets are documented for Succinic Acid?

Succinic Acid has 8 bioactivity rows in this page query. Rendered target entries include Egl nine homolog 1, Succinate receptor 1.